Azetidinecarboxamide derivatives for treating CNS disorders
US6831078B1 · kind B1 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2001 |
| Grant date | Dec 14, 2004 |
| Priority date | — |
| Expiry date | Feb 12, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (1) wherein R1 is aryl; and R2 is hydrogen or alkyl; pharmaceutically acceptable addition compounds thereof; and their use in therapy, particularly for the treatment and prophylaxis of CNS disorders such as anxiety and epilepsy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.